Guidance on Tuberculin Skin Test Shortage

The Virginia Department of Health (VDH) has recently received questions about the recurrent nationwide shortage of Tuberculin Skin Test Antigen Solutions.  A letter from Virginia Health Commissioner, Cynthia C. Romero, MD, FAFP describes the shortage and outlines guidance on how to deal with the shortage in the event our member facilities have questions or need information.  In its September 4, 2013 Health Advisory, the Centers for Disease Control and Prevention (CDC) addresses the nationwide shortages of tuberculin skin test (TST) antigen solutions. Two brands of TST solution are distributed in the United States: Tubersol and Aplisol. Tubersol is in short supply for the second time this year creating an increased demand for Aplisol and, in some areas, resulting in difficulty obtaining either product.  Dr. Romero’s letter identifies CDC’s key recommendations during this TST antigen shortage and the VDH recommendations for health care-related settings, clinicians and local health departments.

Local health district Tuberculosis (TB) Control programs across Virginia are a resource for consultation on the evaluation and treatment of patients with TB diagnoses as well as infection control policies and practices.  Contact information for local health districts throughout Virginia can be found here.  Assistance also is available through the state TB Control program at 804.864.7906.